Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
309
Price
$33.45
Total Value
$10.34K
Shares Held After
24,353
% of Holdings
1.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
34,091
Price
$32.77
Total Value
$1.12M
Shares Held After
24,662
% of Holdings
58.0%
Taysha Gene Therapies, Inc. (TSHA)
Nagendran Sukumar — Director
Shares
26,918
Price
$4.61
Total Value
$124.09K
Shares Held After
1,317,389
% of Holdings
2.0%
Taysha Gene Therapies, Inc. (TSHA)
Nolan Sean P. — Director
Shares
41,312
Price
$4.61
Total Value
$190.45K
Shares Held After
2,908,257
% of Holdings
1.4%
Taysha Gene Therapies, Inc. (TSHA)
Alam Kamran — CHIEF FINANCIAL OFFICER
Shares
23,849
Price
$4.61
Total Value
$109.94K
Shares Held After
1,443,786
% of Holdings
1.6%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
1,053
Price
$96.19
Total Value
$101.29K
Shares Held After
43,741
% of Holdings
2.4%
Mirum Pharmaceuticals, Inc. (MIRM)
Radovich Peter — PRESIDENT AND COO
Shares
3,143
Price
$96.19
Total Value
$302.33K
Shares Held After
23,286
% of Holdings
11.9%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
842
Price
$96.19
Total Value
$80.99K
Shares Held After
3,700
% of Holdings
18.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
6,831
Price
$96.19
Total Value
$657.09K
Shares Held After
169,402
% of Holdings
3.9%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Huntsman Carole — Chief Commercial Officer
Shares
570
Price
$494.59
Total Value
$281.92K
Shares Held After
9,122
% of Holdings
5.9%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Huntsman Carole — Chief Commercial Officer
Shares
340
Price
$492.42
Total Value
$167.42K
Shares Held After
9,692
% of Holdings
3.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
1,577
Price
$492.42
Total Value
$776.55K
Shares Held After
148,497
% of Holdings
1.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Taub Rebecca — Director
Shares
647
Price
$492.42
Total Value
$318.60K
Shares Held After
452,704
% of Holdings
0.1%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
8,135
Price
$30.01
Total Value
$244.15K
Shares Held After
419,173
% of Holdings
1.9%
Protagonist Therapeutics, Inc. (PTGX)
PATEL DINESH V PH D — Director
Shares
19,315
Price
$84.59
Total Value
$1.63M
Shares Held After
574,505
% of Holdings
3.3%
Protagonist Therapeutics, Inc. (PTGX)
MOLINA ARTURO MD — Chief Medical Officer
Shares
13,151
Price
$82.42
Total Value
$1.08M
Shares Held After
84,115
% of Holdings
13.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
12,767
Price
$34.37
Total Value
$438.80K
Shares Held After
24,353
% of Holdings
34.4%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
25,405
Price
$33.44
Total Value
$849.54K
Shares Held After
37,120
% of Holdings
40.6%
Mirum Pharmaceuticals, Inc. (MIRM)
Heron Patrick J — Director
Shares
131,425
Price
$68.48
Total Value
$9.00M
Shares Held After
459,010
% of Holdings
28.6%
Taysha Gene Therapies, Inc. (TSHA)
Nagendran Sukumar — Director
Shares
89,132
Price
$4.75
Total Value
$423.38K
Shares Held After
1,344,307
% of Holdings
6.2%
Taysha Gene Therapies, Inc. (TSHA)
Nolan Sean P. — Director
Shares
136,789
Price
$4.75
Total Value
$649.75K
Shares Held After
2,949,569
% of Holdings
4.4%
Taysha Gene Therapies, Inc. (TSHA)
Alam Kamran — CHIEF FINANCIAL OFFICER
Shares
78,968
Price
$4.75
Total Value
$375.10K
Shares Held After
1,467,635
% of Holdings
5.1%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
20,000
Price
$40.26
Total Value
$805.11K
Shares Held After
20,000
% of Holdings
50.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,151
Price
$55.98
Total Value
$64.43K
Shares Held After
449,844
% of Holdings
0.3%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,556
Price
$5.27
Total Value
$29.28K
Shares Held After
599,603
% of Holdings
0.9%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
5,633
Price
$1.90
Total Value
$10.72K
Shares Held After
173,999
% of Holdings
3.1%
CRISPR Therapeutics AG (CRSP)
Prasad Raju — Chief Financial Officer
Shares
34,972
Price
$60.19
Total Value
$2.10M
Shares Held After
6,767
% of Holdings
83.8%
Sionna Therapeutics, Inc. (SION)
TPG GP A, LLC — 10% Owner
Shares
250,000
Price
$40.00
Total Value
$10.00M
Shares Held After
6,494,962
% of Holdings
3.7%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
12,610
Price
$5.29
Total Value
$66.66K
Shares Held After
318,619
% of Holdings
3.8%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
3,828
Price
$18.10
Total Value
$69.30K
Shares Held After
210,164
% of Holdings
1.8%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
1,882
Price
$18.15
Total Value
$34.16K
Shares Held After
145,355
% of Holdings
1.3%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
5,000
Price
$45.52
Total Value
$227.61K
Shares Held After
12,965
% of Holdings
27.8%
Beam Therapeutics Inc. (BEAM)
Cavanagh Bethany J — SVP, Finance and Treasurer
Shares
6,198
Price
$35.00
Total Value
$216.93K
Shares Held After
34,813
% of Holdings
15.1%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
1,371
Price
$34.00
Total Value
$46.61K
Shares Held After
95,667
% of Holdings
1.4%
CEL-SCI Corporation (CVM)
KERSTEN GEERT R — Director
Shares
38,023
Price
$5.26
Total Value
$200.00K
Shares Held After
120,815
% of Holdings
31.5%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
2,500
Price
$2.95
Total Value
$7.38K
Shares Held After
0
% of Holdings
100.0%
Apellis Pharmaceuticals, Inc. (APLS)
Baumal Caroline — Chief Medical Officer
Shares
2,797
Price
$21.77
Total Value
$60.88K
Shares Held After
86,527
% of Holdings
3.1%
Apellis Pharmaceuticals, Inc. (APLS)
Chopas James George — VP/Chief Accounting Officer
Shares
2,064
Price
$21.77
Total Value
$44.92K
Shares Held After
49,805
% of Holdings
4.0%
Apellis Pharmaceuticals, Inc. (APLS)
DeLong Mark Jeffrey — Chief Business & Strat Officer
Shares
3,371
Price
$21.77
Total Value
$73.37K
Shares Held After
78,353
% of Holdings
4.1%
Apellis Pharmaceuticals, Inc. (APLS)
Deschatelets Pascal — Chief Scientific Officer
Shares
5,928
Price
$21.77
Total Value
$129.03K
Shares Held After
1,151,382
% of Holdings
0.5%
Apellis Pharmaceuticals, Inc. (APLS)
Francois Cedric — Director
Shares
27,192
Price
$21.77
Total Value
$591.84K
Shares Held After
286,045
% of Holdings
8.7%
Apellis Pharmaceuticals, Inc. (APLS)
Nicholson Nur — Chief Technical Officer
Shares
7,725
Price
$21.77
Total Value
$168.14K
Shares Held After
71,118
% of Holdings
9.8%
Apellis Pharmaceuticals, Inc. (APLS)
Sullivan Timothy Eugene — Chief Financial Officer
Shares
10,287
Price
$21.77
Total Value
$223.90K
Shares Held After
93,901
% of Holdings
9.9%
Apellis Pharmaceuticals, Inc. (APLS)
Watson David O. — General Counsel
Shares
7,832
Price
$21.77
Total Value
$170.47K
Shares Held After
88,531
% of Holdings
8.1%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
14,300
Price
$110.16
Total Value
$1.58M
Shares Held After
59,634
% of Holdings
19.3%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
12,779
Price
$46.85
Total Value
$598.75K
Shares Held After
85,660
% of Holdings
13.0%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
2,119
Price
$45.87
Total Value
$97.19K
Shares Held After
98,439
% of Holdings
2.1%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
3,977
Price
$81.34
Total Value
$323.49K
Shares Held After
22,541
% of Holdings
15.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
2,173
Price
$56.57
Total Value
$122.92K
Shares Held After
448,693
% of Holdings
0.5%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,665
Price
$5.32
Total Value
$67.38K
Shares Held After
605,159
% of Holdings
2.0%
Showing 101–150 of 1179 transactions (page 3 of 24)